{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:13:41Z","timestamp":1778339621874,"version":"3.51.4"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003411","name":"Gangneung Asan Hospital","doi-asserted-by":"crossref","award":["no"],"award-info":[{"award-number":["no"]}],"id":[{"id":"10.13039\/501100003411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>This study investigated whether administering erythropoiesis-stimulating agents (ESAs) improves endothelial function in patients with non-dialysis chronic kidney disease (CKD) and anemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This single-center, prospective, single-arm comparison study enrolled patients with non-dialysis CKD (stages 4-5) and hemoglobin levels &lt;10\u200ag\/dL. ESA administration followed the Kidney Disease: Improving Global Outcomes guideline. The primary endpoint was the change in flow-mediated dilatation after ESA administration in individual patients. The secondary endpoints were changes in 6-minute walk test results, blood pressure, New York Heart Association class, and echocardiographic parameters. The echocardiographic parameters examined included chamber quantification, Doppler parameters, and systolic and diastolic function parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Initially, 13 patients were screened, but 2 discontinued due to either heart failure or voluntary withdrawal. The mean flow-mediated dilatation values significantly increased by 10.59% (from 1.36%\u200a\u00b1\u200a1.91% to 11.95%\u200a\u00b1\u200a8.11%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.001). Echocardiographic findings showed that the left ventricular mass index decreased by 11.9\u200ag\/m<jats:sup>2<\/jats:sup> (from 105.8\u200a\u00b1\u200a16.3 to 93.9\u200a\u00b1\u200a19.5\u200ag\/m<jats:sup>2<\/jats:sup>, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a\n                                 <jats:italic toggle=\"yes\">=<\/jats:italic>\u200a\n                                 <jats:italic toggle=\"yes\">.006<\/jats:italic>), and the left atrial volume index decreased by 10.8\u200amL\/m<jats:sup>2<\/jats:sup> (from 50.1\u200a\u00b1\u200a11.3 to 39.3\u200a\u00b1\u200a11.3\u200amL\/m<jats:sup>2<\/jats:sup>, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.004) after 12\u200aweeks of ESA administration. There were no significant differences between pre- and post-ESA treatment 6-minute walk test results. No significant side effects were observed during the study period.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This is the first clinical study to demonstrate that an ESA improves endothelial dysfunction, left ventricular hypertrophy, and left atrial volume in patients with non-dialysis CKD. Thus, ESAs may be considered as adjunctive therapy for reducing cardiovascular risk in these patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027601","type":"journal-article","created":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T02:03:18Z","timestamp":1634954598000},"page":"e27601","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Erythropoietin therapy improves endothelial function in patients with non-dialysis chronic kidney disease and anemia (EARNEST-CKD)"],"prefix":"10.1097","volume":"100","author":[{"given":"Jina","family":"Lim","sequence":"first","affiliation":[{"name":"Department of Internal Medicine-Nephrology, GangNeung Asan Hospital, GangNeung, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Jo","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine-Cardiology, GangNeung Asan Hospital, GangNeung, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3285-6324","authenticated-orcid":false,"given":"Hoon","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine-Nephrology, GangNeung Asan Hospital, GangNeung, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Jin","family":"Ha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine-Cardiology, GangNeung Asan Hospital, GangNeung, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ki.1995.22","article-title":"Clinical and echocardiographic disease in patients starting end-stage renal disease therapy","volume":"47","author":"Foley","year":"1995","journal-title":"Kidney Int"},{"issue":"(12 Suppl)","key":"R2-20250504","first-page":"S16","article-title":"Epidemiology of cardiovascular disease in chronic renal disease","volume":"9","author":"Foley","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"(Suppl 1)","key":"R3-20250504","first-page":"68","article-title":"Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy","volume":"22","author":"Cases","year":"2002","journal-title":"Nefrologia"},{"issue":"(Suppl 2)","key":"R4-20250504","first-page":"14","article-title":"Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients","volume":"12","author":"van Guldener","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.atherosclerosis.2011.02.017","article-title":"Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients","volume":"216","author":"Recio-Mayoral","year":"2011","journal-title":"Atherosclerosis"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/01.CIR.101.9.1002","article-title":"Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer","volume":"101","author":"Miyazaki","year":"2000","journal-title":"Circulation"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/heart.83.2.205","article-title":"Abnormalities of endothelial function in patients with predialysis renal failure","volume":"83","author":"Thambyrajah","year":"2000","journal-title":"Heart"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/CS20100277","article-title":"Impaired resistance artery function in patients with end-stage renal disease","volume":"120","author":"Luksha","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/10715769900300771","article-title":"Antioxidant status and lipid peroxidation in hemodialysis patients undergoing erythropoietin and erythropoietin-vitamin E combined therapy","volume":"31","author":"Inal","year":"1999","journal-title":"Free Radic Res"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/ajkd.2002.34919","article-title":"Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients","volume":"40","author":"Usberti","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1081\/JDI-120002663","article-title":"Epoetin treatment improves red blood cell and plasma antioxidant capacity in hemodialysis patients","volume":"24","author":"Mimic-Oka","year":"2002","journal-title":"Ren Fail"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5414\/CPP41187","article-title":"Effect of epoetin on HO-1 mRNA level and plasma antioxidants in hemodialysis patients","volume":"41","author":"Cal\u00f2","year":"2003","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R13-20250504","first-page":"908","article-title":"Erythropoietin controls heme metabolic enzymes in normal human bone marrow culture","volume":"17","author":"Abraham","year":"1989","journal-title":"Exp Hematol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1471-4159.2005.03038.x","article-title":"Astroglial cytoprotection by erythropoietin pre-conditioning: implications for ischemic and degenerative CNS disorders","volume":"93","author":"Diaz","year":"2005","journal-title":"J Neurochem"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.STR.0000239787.92203.16","article-title":"Erythropoietin depletes iron stores: antioxidant neuroprotection for ischemic stroke?","volume":"37","author":"Bailey","year":"2006","journal-title":"Stroke"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.ki.5002482","article-title":"Antioxidative effects of erythropoietin","volume":"72","author":"Katavetin","year":"2007","journal-title":"Kidney Int"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/hrt.2010.220798","article-title":"Darbepoetin improves endothelial function and increases circulating endothelial progenitor cell number in patients with coronary artery disease","volume":"97","author":"Mueller","year":"2011","journal-title":"Heart"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000188684","article-title":"Effect of erythropoietin on systolic and diastolic left ventricular function in chronic renal failure with anemia","volume":"71","author":"Ozakgun","year":"1995","journal-title":"Nephron"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2215\/CJN.02730608","article-title":"Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis","volume":"4","author":"Parfrey","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/B978-0-12-385061-4.00009-X","article-title":"Cardiovascular effects of erythropoietin an update","volume":"60","author":"Santhanam","year":"2010","journal-title":"Adv Pharmacol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1345\/aph.1E143","article-title":"Use of erythropoietin in heart failure management","volume":"38","author":"Caiola","year":"2004","journal-title":"Ann Pharmacother"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/FJC.0b013e3181a6ac38","article-title":"Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia","volume":"53","author":"Palazzuoli","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12882-018-1042-y","article-title":"Treating endothelial dysfunction with vitamin D in chronic kidney disease: a meta-analysis","volume":"19","author":"Lundwall","year":"2018","journal-title":"BMC Nephrology"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/nu9080895","article-title":"Omega 3 polyunsaturated fatty acids improve endothelial dysfunction in chronic renal failure: role of eNOS activation and of oxidative stress","volume":"9","author":"Zanetti","year":"2017","journal-title":"Nutrients"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1681\/ASN.2016050521","article-title":"Vascular function and uric acid-lowering in stage 3 CKD","volume":"28","author":"Jalal","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"e000128","DOI":"10.1161\/JAHA.113.000128","article-title":"Effects of recombinant human erythropoietin on resistance artery endothelial function in stage 4 chronic kidney disease","volume":"2","author":"Briet","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2015.09.034","article-title":"Epoetin beta pegol prevents endothelial dysfunction as evaluated by flow-mediated dilation in chronic kidney disease rats","volume":"767","author":"Serizawa","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.echo.2009.07.013","article-title":"Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography","volume":"22","author":"Zoghbi","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"issue":"(Suppl 3)","key":"R31-20250504","first-page":"36","article-title":"Reference range for brachial artery flow-mediated dilation in healthy Chinese children and adolescents","volume":"24","author":"Li","year":"2018","journal-title":"Hong Kong Med J"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1046\/j.1523-1755.2003.00852.x","article-title":"Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure","volume":"63","author":"Cross","year":"2003","journal-title":"Kidney Int"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00467-004-1495-z","article-title":"Growth hormone therapy influences endothelial function in children with renal failure","volume":"19","author":"Lilien","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1046\/j.1523-1755.2001.00059.x","article-title":"Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure","volume":"60","author":"Cross","year":"2001","journal-title":"Kidney Int"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1681\/ASN.V12122747","article-title":"Oxidative stress and endothelial function in chronic renal failure","volume":"12","author":"Annuk","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.atherosclerosis.2015.01.034","article-title":"Urea-induced ROS cause endothelial dysfunction in chronic renal failure","volume":"239","author":"D\u2019Apolito","year":"2015","journal-title":"Atherosclerosis"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"954","DOI":"10.12659\/MSM.884024","article-title":"Effect of methoxy polyethylene glycol-epoetin beta on oxidative stress in predialysis patients with chronic kidney disease","volume":"19","author":"Bartnicki","year":"2013","journal-title":"Med Sci Monit"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2147\/VHRM.S2769","article-title":"Measurement of endothelial function and its clinical utility for cardiovascular risk","volume":"4","author":"Al-Qaisi","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.109.864801","article-title":"Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis","volume":"120","author":"Yeboah","year":"2009","journal-title":"Circulation"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1097\/01.ASN.0000145436.09176.A7","article-title":"Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials","volume":"15","author":"Strippoli","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/ndt\/gfx324","article-title":"Mechanisms and mediators of hypertension induced by erythropoietin and related molecules","volume":"33","author":"Agarwal","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"R44-20250504","first-page":"220","article-title":"Blood pressure increase after erythropoietin injection in hemodialysis and predialysis patients","volume":"7","author":"Noshad","year":"2013","journal-title":"Iran J Kidney Dis"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0272-6386(97)90335-8","article-title":"Cardiovascular effects of recombinant human erythropoietin in predialysis patients","volume":"29","author":"Portol\u00e9s","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0272-6386(00)70334-9","article-title":"Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure","volume":"35","author":"Hayashi","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/01.ASN.0000102471.89084.8B","article-title":"Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial","volume":"15","author":"Roger","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1523-1755.2005.00458.x","article-title":"Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10\u200ag\/dL","volume":"68","author":"Ayus","year":"2005","journal-title":"Kidney Int"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/jce.12978","article-title":"Left atrial geometry improves risk prediction of thromboembolic events in patients with atrial fibrillation","volume":"27","author":"Bisbal","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.hrthm.2016.05.028","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"14","author":"Goette","year":"2017","journal-title":"Heart Rhythm"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0002-9149(02)02864-3","article-title":"Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden","volume":"90","author":"Tsang","year":"2002","journal-title":"Am J Cardiol"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","article-title":"Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial","volume":"316","author":"Eschbach","year":"1987","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:02:31Z","timestamp":1746338551000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027601"}},"subtitle":["A clinical study"],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":52,"journal-issue":{"issue":"42","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027601","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,22]]},"assertion":[{"value":"2021-04-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}